There was no evidence of ERBB2 amplification or HER2 overexpression in the primary tumor specimen taken at the time of diagnosis; tissue genotyping demonstrated only CCNE1 gene amplification when DNA was extracted from baseline tumor biopsy. The gene discussed is ERBB2; the disease is neoplasm.